◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
KYORIN Pharmaceutical Co.,Ltd. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2025Mar 31, 2025FY 2024Mar 31, 2024FY 2023Mar 31, 2023FY 2022Mar 31, 2022FY 2021Mar 31, 2021
+Revenue 130.1B 119.5B 113.3B 105.5B 102.9B
Revenue Growth % 8.8% 5.5% 7.3% 2.6% --
+Operating Income 12.6B 6.0B 5.1B 5.0B 5.8B
Operating Margin % 9.7% 5.0% 4.5% 4.7% 5.6%
Non Operating Income 870.0M 735.0M 799.0M 677.0M 798.0M
Non Operating Expenses 218.0M 146.0M 94.0M 115.0M 137.0M
Ordinary Income 13.2B 6.6B 5.8B 5.6B 6.4B
Income Before Taxes 12.8B 7.0B 6.9B 5.2B 8.4B
Income Taxes 3.7B 1.7B 2.2B 1.3B 2.2B
+Net Income 9.1B 5.3B 4.7B 3.9B 6.1B
Net Margin % 7.0% 4.5% 4.2% 3.7% 6.0%
Eps 158.17 92.74 82.44 68.62 106.99
Depreciation Amortization 4.6B 4.3B 3.8B 3.7B 3.6B
Line ItemFY 2025Mar 31, 2025FY 2024Mar 31, 2024FY 2023Mar 31, 2023FY 2022Mar 31, 2022FY 2021Mar 31, 2021
Cash And Deposits 15.0B 13.9B 19.4B 27.0B 27.4B
Current Assets 136.1B 119.3B 119.0B 116.4B 114.0B
Property Plant Equipment 30.3B 28.9B 25.8B 24.3B 23.9B
Noncurrent Assets 57.5B 58.4B 57.0B 55.5B 53.1B
Total Assets 193.6B 177.7B 176.0B 171.9B 167.1B
Current Liabilities 35.1B 45.5B 35.0B 32.2B 27.4B
Total Liabilities 57.3B 46.9B 50.6B 47.4B 42.5B
Retained Earnings 142.8B 136.8B 134.4B 132.7B 132.6B
Total Equity 136.3B 130.8B 125.5B 124.5B 124.7B
Equity Ratio 0.70 0.74 0.71 0.72 0.75
Book Value Per Share 2,372 2,277 2,189 2,173 2,176
Num Employees 1,998 2,042 2,138 2,222 2,243
Roe 0.07 0.04 0.04 0.03 0.05
Line ItemFY 2025Mar 31, 2025FY 2024Mar 31, 2024FY 2023Mar 31, 2023FY 2022Mar 31, 2022FY 2021Mar 31, 2021
Operating Cash Flow 3.5B 1.5B 2.0B 6.3B 5.2B
Investing Cash Flow -6.3B -3.2B -6.3B -2.6B -4.3B
Financing Cash Flow 4.0B -3.3B -3.4B -4.1B -4.9B
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...